跳至主要内容
临床试验/NCT05633134
NCT05633134尚未招募不适用

Precision Preoperative Embolization of Pelvic Tumors to Improve Surgical Outcomes

Peking University People's Hospital0 个研究点目标入组 120 人开始时间: 2023年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
120
主要终点
Perioperative blood loss

研究概览

简要总结

The main purpose of this study is to assess the efficacy of precision preoperative embolization in decreasing operative blood loss, reducing surgical complications in pelvic tumor surgery. Furthermore the study aims at describing the vascularity in a series of pelvic tumors, and to correlate this with perioperative blood loss.

详细描述

The main purpose of this study is to assess the efficacy of precision preoperative embolization in decreasing operative blood loss, reducing surgical complications in pelvic tumor surgery,which including poor wound healing,nerve injury,and pelvic organs dysfunction. Furthermore the study aims at describing the vascularity in a series of pelvic tumors,which contains four grade:poor,moderate,rich and abundant and to correlate this with perioperative blood loss.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Primary or metastatic pelvic tumor
  • Confirmed by contrast-enhanced magnetic resonance imaging (MRI) or computed tomography (CT) of the pelvic
  • Planned surgical resection

排除标准

  • Contrast medium allergy
  • Uncontrolled or concurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements

结局指标

主要结局

Perioperative blood loss

时间窗: Measured intraoperatively

Perioperative blood loss measured intraoperatively

次要结局

  • Vascularization grade of pelvic tumors(At the angiographic procedure prior to embolization performed 0-24 hours before surgery)
  • postoperative blood loss(Within 2 postoperative days)
  • Adverse events related to angiography or embolization(Within 2 postoperative days)
  • Adverse events related to surgery(Within 30 postoperative days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhi Xin

Doctor

Peking University People's Hospital

相似试验